American Pharmaceutical Association.A review of the new smoking cessation strategies from the Agency for Health Care Policy and Research (special report). Washington, DC: American Pharmaceutical Association, 1996.
2.
Department of Health and Human Services.Smoking cessation. DHHS publication no. (PHS) 96–0692. Washington, DC: Government Printing Office, 1996.
3.
JosephAMNormanSMFerryLHProchazkaAVWestmanECSteeleBGThe safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med1996;335:1792–8.
4.
Department of Health and Human Services.The health consequences of smoking: cardiovascular disease: a report of the Surgeon General. DHHS publication no. (PHS) 84–50204. Washington, DC: Government Printing Office, 1983.
5.
CryerPEHaymondMWSantiagoJVShahSD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med1976;295:573–7.
6.
HungJLamJYTLacosteLLetchacovskiG. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation1995;92:2432–6.
7.
BlackHR. Smoking and cardiovascular disease. In: LaraghJHBrennerBM, eds. Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press, 1990:1917–36.
8.
Department of Health and Human Services.The health benefits of smoking cessation: a report of the Surgeon General. DHHS publication no. (CDC) 90–8416. Washington, DC: Government Printing Office, 1990.
9.
OckeneJKKullerLHSvendsenKHMeilahnE. The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Public Health1990;80:954–8.
10.
HenningfieldJE. Nicotine medications for smoking cessation. N Engl J Med1995;333:1196–203.
11.
FioreMCSmithSSJorenbyDEBakerTB. The effectiveness of the nicotine patch for smoking cessation: A meta-analysis. JAMA1994;271:1940–7.
12.
AllenSSHatsukameDGorslineJ. The Transdermal Nicotine Study Group. Cholesterol changes in smoking cessation using the transdermal nicotine system. Prev Med1994;23:190–6.
13.
Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med1994;154:989–95.
14.
USP dispensing information. Vol. I. Drug information for the health care professional. 16th ed. Tauton, MA: Rand McNally, 1996:2176.